Table 3

Yield of clinical staging

MCAVUMC
(n=253)(n=142)
VUMC = VU University Medical Centre, Amsterdam; MCA = Medical Centre Alkmaar. *p<0.01; **p=0.001.
After 1st screening (n)220117
Clinically unresectable (III/IV)121 48
Clinically resectable(I/II) 99 69
Thoracotomy 85 (100%) 59 (100%)
Benign 9 (11%) 10 (17%)*
Irresectable at surgery 10 (12%) 23 (39%)
    T stage 7 13*
    N stage 3 8*
    M stage 0 2
Recurrence after radical surgery in NSCLC 13 (15%) 7 (12%)
    Local 0 1
    Brain 2 1
    Bone 4 0
    Liver 1 0
    Mediastinum 2 2
    Other 4 3
Recurrence <1 year after surgery in other malignancy 2 (2%) 0
Total futile surgery 34 (40%) 40 (68%)**